Page last updated: 2024-09-05

sorafenib and sulfur hexafluoride

sorafenib has been researched along with sulfur hexafluoride in 2 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (sulfur hexafluoride)	Trials (sulfur hexafluoride)	Recent Studies (post-2010) (sulfur hexafluoride)
6,520	730	5,251	2,667	180	1,197

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chami, L; Escudier, B; Lamuraglia, M; Lassau, N; Leclère, J; Roche, A; Schwartz, B	1
Bawa, O; Benatsou, B; Koscielny, S; Lassau, N; Leguerney, I; Massard, C; Opolon, P; Peronneau, P; Roche, A; Rodrigues, M; Rouffiac, V; Thalmensi, J	1

Other Studies

2 other study(ies) available for sorafenib and sulfur hexafluoride

Article	Year
To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound. European journal of cancer (Oxford, England : 1990), 2006, Volume: 42, Issue:15 Topics: Adult; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Contrast Media; Disease Progression; Disease-Free Survival; Double-Blind Method; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Phospholipids; Pilot Projects; Pyridines; Randomized Controlled Trials as Topic; Sorafenib; Sulfur Hexafluoride; Survival Analysis; Treatment Outcome; Ultrasonography, Doppler	2006
Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments. Investigational new drugs, 2012, Volume: 30, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bevacizumab; Contrast Media; Drug Administration Schedule; Extracellular Fluid; Female; Fiber Optic Technology; Melanoma, Experimental; Mice; Neovascularization, Pathologic; Niacinamide; Perfusion Imaging; Phenylurea Compounds; Phospholipids; Pressure; Pyridines; Regional Blood Flow; Sorafenib; Sulfur Hexafluoride; Time Factors; Transducers, Pressure; Ultrasonography, Doppler	2012

Article

Year

To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound.

European journal of cancer (Oxford, England : 1990), 2006, Volume: 42, Issue:15

Topics: Adult; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Contrast Media; Disease Progression; Disease-Free Survival; Double-Blind Method; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Phospholipids; Pilot Projects; Pyridines; Randomized Controlled Trials as Topic; Sorafenib; Sulfur Hexafluoride; Survival Analysis; Treatment Outcome; Ultrasonography, Doppler

2006

Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments.

Investigational new drugs, 2012, Volume: 30, Issue:1

Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bevacizumab; Contrast Media; Drug Administration Schedule; Extracellular Fluid; Female; Fiber Optic Technology; Melanoma, Experimental; Mice; Neovascularization, Pathologic; Niacinamide; Perfusion Imaging; Phenylurea Compounds; Phospholipids; Pressure; Pyridines; Regional Blood Flow; Sorafenib; Sulfur Hexafluoride; Time Factors; Transducers, Pressure; Ultrasonography, Doppler

2012